Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonists.
The synthesis and biological testing of novel classes of potent melanin-concentrating hormone (MCH-R1) antagonists based on pyrazolopiperazinone and pyrrolopiperazinone scaffolds are described.